Disclaimer: This blog post focuses on a new piece of research from Rethink Priorities. I was not involved with the funding or execution of this research, and therefore write this piece merely as a consumer. However, I am the Executive Director of Giving Green and a board member of Rethink Priorities, and acknowledge that these affiliations may bias my...
I am writing up two charity ideas I’ve wanted to investigate, but haven’t been able to, in the hopes someone will investigate them further. If you end up investigating either, I'd be most interested to see what conclusions you come to!
Vulture preservation as a global health intervention
Since the mid 1990's the vulture population in India has been rapidly declining. The reason is due to a few chemicals which are fed to livestock, which is highly poisonous to vultures.
...
Michael Nielsen has a beautiful new essay on moral imagination: the ability humans have to 'develop and transmit new notions of good action, indeed, even new kinds of good'.
As examples, he gives:
* Hammurabi's creation of a code of laws (in 1754 BCE) and his justification of his rule not in terms of divine or hereditary right, but by the delivery of justice to his citizens.
* St Gregory of Nyssa's...
New anti-malaria treatment clears phase 3 trials.
I just found that there is a new anti-malarial alternative to artemisinin, the most common antimalarial chemical, which has successfully completed Phase 3 trials. Its nickname is GanLum and apparently has quite powerful effects:
This is an important advance because resistance to artemisinin is one of the growing concerns in the fight against malaria.
You may read more in https://www.npr.org/sections/goats-and-soda/2025/11/12/g-s1-97487/malaria-drug-new and https://www.mmv.org/newsroom/news-resources-search/phase-3-trial-next-generation-malaria-treatment-ganaplacide-lumefantrine .
Very interesting! And very hopeful! Thanks for sharing!